NATIONAL INSTITUTE FOR HEALTH RESEARCH
Health Technology Assessment
(NIHR HTA) programme
• Award winner: Charles Knowles
• Institution: Barts and the London School of Medicine and Dentistry
• Value: £529,685
Control of faecal incontinence using distal neuromodulation
THE LEVERHULME TRUST
Research Fellowships
• Award winner: Elizabeth Archibald
• Institution: University of Bristol
Baths and bathing in medieval literature and society
• Award winner: M. Niaz Asadullah
• Institution: University of Reading
The rise of Islamic schools in Bangladesh
• Award winner: David Attwell
• Institution: University of York
J.M. Coetzee: a political life
• Award winner: Estella Baker
• Institution: University of Sheffield
The EU as a penal actor: an investigation of policymaking and governance
• Award winner: Daniel Beer
• Institution: Royal Holloway, University of London
In the depths of Siberia's mines: exile and penal labour in Russia, 1822-1917
• Award winner: Christine Bell
• Institution: University of Edinburgh
Talking about international constitutional law
• Award winner: Debopam Bhattacharya
• Institution: University of Oxford
Subsidised provision of health products with social benefits
• Award winner: Johnston Birchall
• Institution: University of Stirling
Risk and regulation after the banking crisis: harnessing the potential of customer-owned banks
Research Project Grants
• Award winner: Robert G. Endres
• Institution: Imperial College London
• Value: £171,897
Learning and kinetic proofreading for chemical sensing beyond the physical limit
• Award winner: Christophe Aissa
• Institution: University of Liverpool
• Value: £102,324
Molecular hybrids to determine the binding mode of extracellular actin on the surface of cells
Economics, business studies, industrial relations
• Award winner: Xiaohui Liu
• Institution: Loughborough University
• Value: £43,429
CEO compensation, subnational institutions and firm internationalisation
In Detail
• Award winner: Mark Drayson
• Institution: University of Birmingham
• Value: £1,942,789
Tackling early morbidity and mortality in myeloma: assessing the benefits of antibiotic prophylaxis and its effect on healthcare-associated infections
There is a high risk of infection in patients with impaired immune function. Giving these patients antibiotic prophylaxis (AP) is common practice in the NHS. Studies that established the benefit of AP, however, were done before the current rise in healthcare-associated infections. There is an urgent need to study the risks of AP therapy with respect to its effect on carriage rates of infectious organisms. Myeloma is a cancer of bone marrow plasma cells and causes very low immunity, with infections in a quarter of patients. This study will investigate the benefit of antibiotic treatment of myeloma sufferers. The team will assess risks, benefits and cost-effectiveness of antibiotic prophylaxis in newly diagnosed symptomatic myeloma.